Yu Shi

1.5k total citations
60 papers, 1.1k citations indexed

About

Yu Shi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Yu Shi has authored 60 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 21 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in Yu Shi's work include Lung Cancer Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (16 papers) and Cancer-related molecular mechanisms research (10 papers). Yu Shi is often cited by papers focused on Lung Cancer Diagnosis and Treatment (16 papers), Lung Cancer Treatments and Mutations (16 papers) and Cancer-related molecular mechanisms research (10 papers). Yu Shi collaborates with scholars based in China, United States and France. Yu Shi's co-authors include Cheng Zhan, Qun Wang, Wei Jiang, Xiaodong Yang, Zongwu Lin, Fenghao Sun, Junjie Xi, Yongxing Zhang, Ke Ma and Yongxing Zhang and has published in prestigious journals such as Nature Communications, Applied Physics Letters and PLoS ONE.

In The Last Decade

Yu Shi

56 papers receiving 1.1k citations

Peers

Yu Shi
Yu Shi
Citations per year, relative to Yu Shi Yu Shi (= 1×) peers Jiandong Zhao

Countries citing papers authored by Yu Shi

Since Specialization
Citations

This map shows the geographic impact of Yu Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Shi more than expected).

Fields of papers citing papers by Yu Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Shi. The network helps show where Yu Shi may publish in the future.

Co-authorship network of co-authors of Yu Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Shi. A scholar is included among the top collaborators of Yu Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Shi. Yu Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sun, Wenlong, Fu Gui, Marcus Ruscetti, et al.. (2025). SPARC: A Multipayload ADC Architecture for Programmable Drug Combinations. Bioconjugate Chemistry. 36(10). 2158–2171.
2.
Yin, Jiacheng, et al.. (2025). HER2 mutations in pulmonary adenocarcinoma presenting with ground-glass nodules. World Journal of Surgical Oncology. 23(1). 304–304.
3.
Shi, Yu, et al.. (2024). Molecular insights into AGS3’s role in spindle orientation: a biochemical perspective. Journal of Molecular Cell Biology. 16(11). 1 indexed citations
4.
Zhang, Yingxin, Wei Qin, Shaohui Zheng, et al.. (2024). Cytosine base editors with increased PAM and deaminase motif flexibility for gene editing in zebrafish. Nature Communications. 15(1). 9526–9526. 7 indexed citations
5.
Liang, Jiaqi, Guoshu Bi, Qihai Sui, et al.. (2024). Transcription factor ZNF263 enhances EGFR-targeted therapeutic response and reduces residual disease in lung adenocarcinoma. Cell Reports. 43(2). 113771–113771. 20 indexed citations
6.
Yan, Tao, Shijie Zhu, Yu Shi, et al.. (2021). Pan-Cancer Analysis of Atrial-Fibrillation-Related Innate Immunity Gene ANXA4. Frontiers in Cardiovascular Medicine. 8. 713983–713983. 9 indexed citations
7.
Sun, Fenghao, Yiwei Huang, Xiaodong Yang, et al.. (2020). Solid component ratio influences prognosis of GGO-featured IA stage invasive lung adenocarcinoma. Cancer Imaging. 20(1). 87–87. 23 indexed citations
8.
Shi, Yu, et al.. (2020). The fraction of nitrous oxide in oxygen for facilitating lung collapse during one-lung ventilation with double lumen tube. BMC Anesthesiology. 20(1). 180–180. 6 indexed citations
9.
Shi, Yu, Fenghao Sun, Yulin Jin, et al.. (2018). Subxiphoid approach with sternum retractor for mediastinal tumor cephalad to brachiocephalic vein. Journal of Thoracic Disease. 10(6). E473–E475. 1 indexed citations
10.
Yin, Jiacheng, Yong Yang, Ke Ma, et al.. (2018). Clinicopathological characteristics and prognosis of pulmonary pleomorphic carcinoma: a population-based retrospective study using SEER data. Journal of Thoracic Disease. 10(7). 4262–4273. 22 indexed citations
11.
Sun, Fenghao, Junjie Xi, Cheng Zhan, et al.. (2018). Ground glass opacities: Imaging, pathology, and gene mutations. Journal of Thoracic and Cardiovascular Surgery. 156(2). 808–813. 33 indexed citations
12.
Ma, Ke, Cheng Zhan, Shuai Wang, et al.. (2018). Spread Through Air Spaces (STAS): A New Pathologic Morphology in Lung Cancer. Clinical Lung Cancer. 20(2). e158–e162. 21 indexed citations
13.
Sun, Fenghao, Ke Ma, Xiaodong Yang, et al.. (2017). A nomogram to predict prognosis after surgery in early stage non-small cell lung cancer in elderly patients. International Journal of Surgery. 42. 11–16. 40 indexed citations
14.
Wang, Shuai, Ke Ma, Qun Wang, et al.. (2017). The revised staging system for malignant pleural mesothelioma based on surveillance, epidemiology, and end results database. International Journal of Surgery. 48. 92–98. 13 indexed citations
15.
Sun, Fenghao, Cheng Zhan, Xiaodong Yang, et al.. (2016). Is routine dissection of the station 9 lymph nodes really necessary for primary lung cancer?. International Journal of Surgery. 34. 53–57. 10 indexed citations
16.
Zhan, Cheng, Yan Li, Lin Wang, et al.. (2015). Isoform Switch of Pyruvate Kinase M1 Indeed Occurs but Not to Pyruvate Kinase M2 in Human Tumorigenesis. PLoS ONE. 10(3). e0118663–e0118663. 27 indexed citations
17.
Guo, Weigang, Yongxing Zhang, Yi Zhang, et al.. (2015). Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer. International Journal of Molecular Medicine. 36(6). 1720–1726. 40 indexed citations
18.
Ma, Jun, Cheng Zhan, Lin Wang, et al.. (2014). The Sweet Approach Is Still Worthwhile in Modern Esophagectomy. The Annals of Thoracic Surgery. 97(5). 1728–1733. 30 indexed citations
19.
Wang, Lin, Cheng Zhan, Jun Ma, Yu Shi, & Qun Wang. (2014). Collision Tumor of Esophagus: Report of Three Cases. The Annals of Thoracic Surgery. 97(3). 1075–1077. 6 indexed citations
20.
Cai, Rong, Xia Ding, Kechun Zhou, et al.. (2009). Blockade of TRPC6 channels induced G2/M phase arrest and suppressed growth in human gastric cancer cells. International Journal of Cancer. 125(10). 2281–2287. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026